Delivery Order SPE2DB24D2216-SPE2DB25FGPSZ
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $12,759.36 to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Mounjaro (tirzepatide) 7.5 mg/0.5 mL pen injectors. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by July 28, 2025. The order will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro (tirzepatide) 5 mg/0.5 mL pen injections totaling $1,539.10 on September 3, 2025, with completion scheduled for September 4, 2025. This is a firm fixed price delivery order with no set-aside designation, executed under competitive procurement procedures. The pharmaceutical will be delivered to the company's facility in Conshohocken, Pennsylvania, serving as the place of performance....
- The Defense Logistics Agency awarded a delivery order valued at $1,170.98 to AmerisourceBergen Drug Corp for the supply of Mounjaro (tirzepatide) 12.5 mg/0.5 mL pen injections on August 29, 2025, with completion scheduled for September 2, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through the federal procurement process. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a $1,187.75 delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Mounjaro (tirzepatide) 15 mg/0.5 mL pens. This is a firm fixed price, competitively awarded contract with a completion date of August 11, 2025, and represents a child delivery order under AmerisourceBergen's larger prime indefinite delivery contract (IDC) with DLA Troop Support Medical. The work will be performed at the contractor's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Mounjaro (tirzepatide) 10 mg/0.5 mL pen injectors at a ceiling value of $3,281.64. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of July 24, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a small-value pharmaceutical procurement supporting federal...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,482.82 to AmerisourceBergen Drug Corp for Mounjaro (tirzepatide) 5 mg/0.5 mL pen injectors with an ultimate completion date of August 12, 2025. This non-competitive, firm fixed-price delivery order was issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX. The contract was performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $6,560.81 to AmerisourceBergen Drug Corp for Mounjaro (tirzepatide) 5 mg/0.5 mL pens on August 19, 2025, with completion expected by August 20, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award for pharmaceutical supply to support federal medical procurement needs. The product will be performed from AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $18,662.14 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Mounjaro (tirzepatide) 10 mg/0.5 mL pens on August 19, 2025, with completion required by August 20, 2025. This award was made without a set-aside designation through open competition. The order will be fulfilled from AmerisourceBergen's location in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. AmerisourceBergen Drug Corp is a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Mounjaro 10 mg/0.5 mL pen injectors with a ceiling value of $6,286.18 under a firm fixed-price contract type. This delivery order is a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The contract carries no set-aside designation...
- The Defense Logistics Agency awarded a delivery order valued at $1,632.54 to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Mounjaro 10 mg/0.5 ml pen (tirzepatide injection), a diabetes and weight management medication. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award through open competition. The contract is to be completed by August 26, 2025, with performance based in Conshohocken, Pennsylvania, where AmerisourceBergen's...
- SPE2DB24D2216Indefinite Delivery Contract
- SPE2DB24D2216-SPE2DB25FGPSZDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Mounjaro (tirzepatide) 5 mg/0.5 mL pen injectors at a ceiling value of $6,533.90. This is a firm fixed-price delivery order with an ultimate completion date of September 9, 2025, and no set-aside designation. The order was competitively awarded to AmerisourceBergen's Corporate Office, located in Conshohocken, Pennsylvania, which serves as a major pharmaceutical distributor and critical vendor for federal medical procurement supporting military and veteran healthcare systems. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's federal contract portfolio demonstrates extensive experience fulfilling medical supply needs across multiple therapeutic domains, positioning the company as a key provider within the Defense Logistics Agency's medical supply chain infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.5k | 9/8/25 |